On Oct. 14, Vir Biotechnology announced a collaboration agreement with Gilead Sciences worth up to $1.88 billion to explore and develop new cancer treatments for solid tumors. Vir will receive a $90 million upfront payment and up to $45 million in near-term preclinical milestones, and will use its PRO-XTEN masking technology and dAIsy AI platform to design drug candidates.
In an interview, Geely Auto Group CEO Gan Jiayue said charging safety comes first and the company rejects rushed technology. He introduced Geely's AI charging solution, which uses the Xingrui PowerMind energy brain to achieve a peak output of 2.2 MW per gun, along with the new Shield Golden Brick battery ultra-short-blade series and two automatic charging robots expected to launch in Q4 2026. He also revealed that self-developed battery shipments reached 1.1 million units in the first eight months of 2026, cooperation with CATL, and plans to build over 22,000 charging stations by the end of 2027.